PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Finance » Live news: Walmart, CVS and Walgreens to cap purchases of at-home Covid testing kits

Live news: Walmart, CVS and Walgreens to cap purchases of at-home Covid testing kits

by PublicWire
December 21, 2021
in Finance
Reading Time: 1 min read
0

Walmart, CVS and Walgreens have announced limits on the purchases of at-home Covid-19 testing kits due to surging demand across the US spurred by the holiday season and the spread of the Omicron variant.

Walmart said on Tuesday it was experiencing “extremely high demand” for at-home testing kits and, although it had “strong inventory levels nationally in store”, online inventory levels were “more limited”.

Accordingly, a purchase limit of eight testing kits per online order will take effect, the world’s largest retailer said in an emailed statement to the Financial Times. Individual stores would be able to “set their own limits based on local inventory”.

CVS is imposing a similar cap, with both in-store and online customers limited to six test kits per purchase. Due to a recent surge in demand and in order to retain community-based access to testing kits in its physical stores, “there may be temporary out-of-stocks for these products” on its web site, the pharmacy chain said in an emailed statement to the FT.

Rival Walgreens is imposing a four-item limit on purchases of at-home testing kits at the pharmacy chain’s physical and online stores.

Demand for the rapid testing kits surged after Thanksgiving and has continued into this week, prompting the introduction of a cap “in an effort to help improve inventory while we continue to work diligently with our supplier partners to best meet customer demands,” Walgreens spokesperson Emily Hartwig-Mekstan told CNBC on Tuesday.


This post was originally published on this site

Previous Post

Taiwan to restrict tech companies’ sales of China assets

Next Post

China tech stocks stage muted rebound

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Finance

South Korea ‘reviewing various plans’ to stabilise the won

September 15, 2022
0
Finance

European shares edge higher as investors weigh up policy outlook

September 15, 2022
0
Finance

Ethereum ‘Merge’ concludes in key moment for crypto market

September 15, 2022
0
Finance

EU embargo to hit Russian oil output, IEA says

September 14, 2022
0
Finance

European stocks slide after sharp Wall Street sell-off overnight

September 14, 2022
0
Finance

Terry Smith to close emerging markets investment trust

September 14, 2022
0
Next Post

China tech stocks stage muted rebound

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.